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ess: m.unstead@rbht.nSummary Lung function testing has been suggested to provide a potential risk
regarding cross-infection between patients. About 155 patients (86 infectious, 69
non-infectious) used a single use bacterial/viral filter when performing routine lung
function tests. Swabs from the patient side of the filter (Proximal) and the
equipment side (Distal), and two sections of the filter itself were cultured. About 33/
155 samples showed bacterial growth on the Proximal compared with 2/155 on the
Distal side (Po0:01). Growth was obtained from the filter in 125/155 (80.6%) of
cases. Pathogenic micro-organisms such as Pseudomonas aeruginosa (4 cases) and
Staphylococcus aureus (5 cases) were isolated. Appropriate infection control
measures should be used when performing lung function tests.
& 2005 Elsevier Ltd. All rights reserved.Introduction
Lung function tests that involve both expiratory
and inspiratory manoeuvres have been proposed as
a potential source of cross-infection between
patients.1–3 In light of hospital infection control
policies, increased patient awareness and medico-
legal issues there is a need to control for such risk,Elsevier Ltd. All rights reserve
351 8910;
hs.uk (M. Unstead).however small. Although the optimal measures for
prevention of cross-infection have not been uni-
versally accepted, single use bacterial/viral filters
have been proposed as a viable method to reduce
possible risk to patients.4 However, the application
of single use patient filters is not widespread, extra
cost being the major limiting factor. Recent review
articles have called for research into the efficacy of
filters in removing micro-organisms.5
The purpose of this study was to investigate the
transmission of micro-organisms from patient to
equipment during pulmonary function testing andd.
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bacterial/viral filters in both infectious and non-
infectious patient groups.Method
About 155 patients performed routine lung function
assessment consisting of flow volume loops, gas
transfer and body plethysmography (Erich Jaeger
GmbH, Wurzburg, Germany). Instructions and en-
couragement to the subjects were given through-
out the tests by trained personnel. Patients were
instructed to remain in a seated upright position
with nose clips positioned accordingly. The prox-
imal port of the bacterial/viral filter was used as
the mouthpiece, this reduced the deadspace of the
circuitry and also minimised cost. The circuit
consisted of filter/mouthpiece, plastic connector
and pneumotachograph, fixed upright in a bracket
and adjusted so patients were positioned correctly
in relation to the equipment/mouthpiece. During
the tests, patients were asked to refrain from
holding the equipment to reduce any cross-con-
tamination. Patients were split into infectious and
non-infectious cohorts. Infectious patients (n ¼ 86)
were classified as patients with a confirmed
diagnosis making the presence of respiratory
pathogens likely; in this case cystic fibrosis (CF;
n ¼ 44) and bronchiectasis (Bx; n ¼ 42). The non-
infectious group (n ¼ 69) consisted of individuals
not classed infectious and with conditions routinely
tested by the unit: asthma (n ¼ 8), interstitial lung
disease (n ¼ 22), chronic obstructive pulmonary
disease and emphysema (n ¼ 23) or miscellaneous
conditions (n ¼ 16). Tests were performed using a
single use bacterial/viral filter (Spiroguard 2800,
Air Safety Limited, UK: 200 g electrostatic media
with 99.96% stated efficiency at a flow of 720 L/
min). During the tests a total of 8–10 maximal vital
capacity manoeuvres were performed using the
same filter. Upon completion of lung function,
patient filters were collected and heat-sealed in a
plastic-lined foil bag to ensure minimal environ-
mental contamination during transit to the Micro-
biology laboratory.
Bacteriological analysis using standard techni-
ques6 was designed to assess transmission onto and
from equipment, capture of micro-organisms by the
filter itself and any passage of isolates through the
filter onto the equipment.
The patient side of the filter was referred to as
the Proximal side and the equipment side Distal.
Both the Proximal and Distal sides were swabbed
using a sterile swab (Transwabs, Medical Wire andEquipment Co., Wilts, UK). Swabs were then
inoculated onto culture media (blood, MacConkey
and chocolate agar) and then streaked across half
plates. If from clinical details, specific organisms
were sought, Sabouraud, Burkholderia cepacia,
Pseudomonas or Staphylococcal selective media
were also inoculated. All plates were incubated
aerobically at 37 1C, except for chocolate plates,
which were incubated in 4–6% CO2. After 24 and
48 h incubation, colony types present were identi-
fied and enumerated.
In order to determine the total qualitative
bacterial content, two sections of filter material
were cut out from each patient filter using a sterile
scalpel after they were swabbed. For mycobacter-
ial investigation, one section was placed in Dubos
broth supplemented with OADC and PANTA and
incubated for 14 days at 37 1C. The broth was then
sub-cultured onto Lowenstein–Jensen slopes and
incubated for a further 14 days. The second section
was placed in brain–heart infusion broth, incubated
for 24 h at 37 1C, sub-cultured and incubated using
the same methods as for the Proximal and Distal
swabs.
Statistical analysis was performed using McNemar
w2-tests with continuity correction.Results
Bacteriological results obtained from all samples
are displayed in Table 1. Significantly greater
bacterial growth was found on the Proximal side
(33/155) compared with the Distal (2/155) side
(Po0:01). Some growth was obtained from the
filter in 80.6% (125/155) of cases.
No significant differences were found between
infectious and non-infectious groups in transmission
of normal respiratory flora. Of the identifiable
pathogenic organisms found, all were transmitted
by the Infectious group. P. aeruginosa, P. stutzeri
and S. aureus were isolated on the Proximal or
Filter cultures in 9 (10.5%) subjects in this group.
Most of the pathogenic organisms were isolated
from the Filter culture, although S. aureus and P.
aeruginosa were each isolated from the Proximal
site on one occasion. In these cases the same
bacterium was isolated from the Filter culture. No
pathogenic bacteria were isolated from the Distal
site; only two isolates of Coagulase-Negative
Staphylococci (CNS) were obtained from the Distal
site. No pathogenic bacteria were isolated from any
culture taken from the non-infectious cohort.
All samples were processed within 2 h of collec-
tion. Additional samples (n ¼ 10) were inoculated
ARTICLE IN PRESS
Ta
b
le
1
M
ic
ro
-o
rg
an
is
m
s
is
ol
at
ed
fr
om
p
ro
xi
m
al
,
d
is
ta
l
an
d
fi
lt
er
sa
m
p
le
si
te
s.
Is
ol
at
e
Sa
m
p
le
si
te
In
fe
ct
io
us
gr
ou
p
ðn
¼
86
Þ
N
on
-I
nf
ec
ti
ou
s
gr
ou
p
ðn
¼
69
Þ
A
ll
su
b
je
ct
s
ðn
¼
15
5Þ
Pr
ox
im
al
D
is
ta
l
Fi
lt
er
Pr
ox
im
al
D
is
ta
l
Fi
lt
er
Pr
ox
im
al
D
is
ta
l
Fi
lt
er
A
ny
gr
ow
th
17
(1
9.
8%
)
2
(2
.3
%
)
72
(8
3.
7%
)
16
(2
3.
2%
)
0
53
(7
6.
8%
)
33
(2
1.
3%
)
2
(1
.3
%
)
12
5
(8
0.
6%
)
N
o
gr
ow
th
69
(8
0.
2%
)
84
(9
7.
7%
)
14
(1
6.
3%
)
53
(7
6.
8%
)
69
16
(2
3.
2%
)
12
2
(7
8.
7%
)
15
3
(9
8.
7%
)
30
(1
9.
4%
)
A
H
S
9
(1
0.
5%
)
0
12
(2
4.
4%
)
13
.
(1
8.
8%
)
0
5
(7
.2
%
)
22
(1
4.
2%
)
0
17
(1
1.
0%
)
A
er
om
on
as
sa
lm
on
ic
id
a
0
0
1
(1
.2
%
)
0
0
0
0
0
1
(0
.6
%
)
Ba
ci
ll
us
sp
.
0
0
35
(4
0.
7%
)
0
0
27
(3
9.
1%
)
0
0
62
(4
0%
)
C
N
S
6
(7
.0
%
)
2
(2
.3
%
)
17
(1
9.
8%
)
9
(1
3.
0)
0
26
(3
9.
9%
)
15
(9
.7
%
)
2
(1
.3
%
)
40
(2
5.
8%
)
D
ip
th
er
oi
d
s
4
(4
.7
%
)
0
3
(3
.5
%
)
2
(2
.9
%
)
0
0
6
(3
.9
%
)
0
3
(1
.9
%
)
M
ic
ro
co
cc
us
sp
.
0
0
1
(1
.2
%
)
0
0
0
0
0
1
(0
.6
%
)
N
ei
ss
er
ia
sp
.
1
(1
.2
%
)
0
0
2
(2
.9
%
)
0
0
3
(1
.9
%
)
0
0
N
H
S
4
(4
.7
%
)
0
5
(5
.8
%
)
6
(8
.7
%
)
0
5
(7
.2
%
)
10
(6
.5
%
)
0
10
(6
.5
%
)
O
ch
ro
ba
ct
ru
m
an
th
ro
pi
0
0
0
0
0
1
(1
.4
%
)
0
0
1
(0
.6
%
)
Ps
eu
do
m
on
as
ae
ru
gi
no
sa
1
(1
.2
%
)
0
3
(3
.5
%
)
0
0
0
1
(0
.6
%
)
0
3
(1
.9
%
)
Ps
eu
do
m
on
as
st
ut
ze
ri
0
0
1
(1
.2
%
)
0
0
0
0
0
1
(0
.6
%
)
Ra
ls
to
ni
a
pi
ck
et
ii
0
0
1
(1
.2
%
)
0
0
1
(1
.4
%
)
0
0
2
(1
.3
%
)
Sp
hi
ng
.
pa
uc
im
ob
il
is
0
0
0
0
0
1
(1
.4
%
)
0
0
1
(0
.6
%
)
St
ap
hy
lo
co
cc
us
au
re
us
1
(1
.2
%
)
0
4
(4
.7
%
)
0
0
0
1
(0
.6
%
)
0
4
(2
.6
%
)
N
ot
e:
A
H
S:
a-
ha
em
ol
yt
ic
st
re
p
to
co
cc
i,
C
N
S:
co
ag
ul
as
e-
ne
ga
ti
ve
st
ap
hy
lo
co
cc
i,
N
H
S:
no
n-
ha
em
ol
yt
ic
st
re
p
to
co
cc
i.
M
et
hi
ci
ll
in
-r
es
is
ta
nt
St
ap
hy
lo
co
cc
us
au
re
us
,
Bu
rk
ho
ld
er
ia
ce
pa
ci
a
an
d
M
yc
ob
ac
te
ri
a
w
er
e
no
t
is
ol
at
ed
fr
om
an
y
te
st
.
M. Unstead et al.948
ARTICLE IN PRESS
Prevention of equipment contamination during lung function assessment 949within the lung function unit immediately after
collection to assess if a delay of 2 h caused any
potential growth to go undetected. No significant
differences were found between the samples
inoculated in the lung function unit and in the
bacteriology laboratory.Discussion
The results of the study demonstrate significant
removal of micro-organisms carried in exhaled
breath by bacterial/viral filters during routine lung
function assessment. All pathogenic isolates passed
onto the filter were from CF and Bx patients. As
part of clinical visit, 35 subjects provided sputum
samples 24 h pre- or post-lung function testing. All
subjects who grew pathogens on the filter itself
were also positive in their sputum sample and
therefore if a filter had not been used transmission
onto equipment would have occurred. Recent
recommendations for infection control in CF out-
line care should be taken regardless of microbiol-
ogy results.7 In accordance with such guidelines
findings from the present study suggest that around
10% of the CF/Bx group transmitted pathogens onto
the filter. This supports previous data from Leeming
et al.8 and reflects the large numbers of bacteria
that frequently colonise the respiratory tract of
these patients.
Pathogens such as Haemophillus influenzae,
Streptococcus pneumoniae and Moraxella catar-
rhalis were not isolated from filters of the
Infectious group. This may be due to the excessive
growth of Bacillus species on the filter material.
Filter samples (40%) grew a background level of
Bacillus spores. Ten filters packaged as sterile
(Spiroguard 2800/01S, Air Safety Limited, UK) were
sampled and grew no Bacillus spp. Due to the rapid
growth characteristics of Bacillus spp., it seems
reasonable to suggest that overgrowth of this
organism in broth culture may have obscured that
of more fastidious respiratory pathogens.
The Infectious group, due to their significant lung
function impairment with predominantly low ex-
piratory flow rates, may have reduced the number
of pathogens isolated, which was lower than
expected. The environment of the filter itself,
which involves hydrostatically charged polymers is
not conducive to bacterial growth, potentially
underestimating bacterial load onto the equip-
ment. However, the rapid transfer to the micro-
biology laboratory that we performed makes it
likely that this was a less important factor. It ispossible that bacteria may have been held on the
filter and not transmitted to the broth media.
CNS colonies (1.3%) were identified on the Distal
side. This was most probably artefactual. CNS
growth was not found on the Proximal side of the
affected filters suggesting origins in collection or
analysis. This could possibly be due to inadvertent
mishandling of the samples by laboratory staff or by
patients. Unpublished data collected from this unit
over 7 years has only shown environmental growth
such as Staphlycoccus epidermidis (a CNS species)
from equipment on the distal side of filters. No
pathogens have ever been grown on the distal port.
Future investigations may wish to isolate infec-
tious groups and directly compare sputum growth
with bacterial load onto equipment. A study into
the filter environment may also be useful, perhaps
introducing a known bacterial load and observing
growth patterns. An additional study group that
performs lung function without a filter may show
differences in growth patterns between filters and
equipment itself.
It is widely recognised that respiratory testing
equipment is not sterile9 and that exposure to
normal levels of environmental organisms during
testing poses no greater risk than being in other
public areas.5 However, we use bacterial/viral
filters on all subjects performing tests within the
department, because we presuppose that anyone
may be ‘potentially’ infectious irrespective of
clinical information provided. In addition, we
disinfect relevant equipment on a regular basis
and always when a patient is known to be infectious
in order to provide ultra clean conditions. This
study demonstrates that pathogenic bacteria such
as P. aeruginosa and S. aureus could pass onto
equipment if filters are not used.References
1. Clausen JL. Lung volume equipment and infection control.
ERS/ATS workshop report series. Eur Resp J 1997;10(8):
1928–32.
2. Rutala DR, Rutala WA, Weber DJ, Thoman CA. Infection risks
associated with spirometry. Infect Control Hosp Epidemiol
1991;12:89–92.
3. Hazaleus RE, Cole J, Berdischewsk M. Tuberculin skin test
conversion from exposure to contaminated pulmonary func-
tion testing apparatus. Respir Care 1981;26:53–5.
4. Strauss R, Wasser F, Mueller RL, Reim E, Wirtz P, Hahn EG, et al.
Effect of a filter system on measurement data and bacterial
contamination in lung function studies. Pneumologie 1993;
47(11):626–30.
5. Kendrick AH, Johns DP, Leeming JP. Infection control of lung
function equipment: a practical approach. Respir Med 2003;
97:1163–79.
ARTICLE IN PRESS
M. Unstead et al.9506. Collins CH, Lyne PM, Grange JM. Collins and Lyne’s micro-
biological methods, 7th ed. Great Britain: Butterworth-
Heinemann; 1995.
7. Salman L, Siegel J. Infection control recommendations for
patients with cystic fibrosis: microbiology, important patho-
gens, and infection control practices to prevent patient-to-
patient transmission. Infect Control Hosp Epidemiol 2003;
24(5):S6.8. Leeming JP, Pryce-Roberts DM, Kendrick AH, Smith EC. The
efficacy of filters used in respiratory function apparatus.
J Hosp Infect 1995;31:205–10.
9. Burgos F, Torres A, Gonza´lez J, Puig-de-la-Bellacasa J,
Rodrigez-Roisin R, Roca J. Bacterial colonisation as
a potential source of nosocomial respiratory infections
in two types of spirometer. Eur Respir J 1997;9(12):
2612–7.
